Author

Taylor B. Crawford

Philadelphia VA Medical Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:GWAS / association mapping· 1 Assay:GWAS summary statistics· 1 Research Focus:variant calling· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Isla P. GarrawayiD· 2 shared Kara N. MaxwelliD· 2 shared Ryan M. HausleriD· 2 shared Alexandra O. SokolovaiD· 1 shared Brent Shane RoseiD· 1 shared Caitlin Orr· 1 shared Carolyn S. MenendeziD· 1 shared Catherine Wolfe· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Isla P. GarrawayORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pathogenic germline variants in a racially diverse real-world cohort of prostate cancer patients

Taylor B. Crawford, Maliha N Tayeb, Emanuel Barrett, Tara Al-Saleem, Pranavi Kondam, Ryan M. Hausler, Heather Symecko, Caitlin Orr, Catherine Wolfe, Derek Mann, Kelsey Spielman, Gloria Wong, Naomi Balzer Haas, Vivek Narayan, Kyle William Robinson, , Kara N. Maxwell

This study reports a 5.4% rate of pathogenic germline variants in a racially diverse cohort of prostate cancer patients, with significant associations between PGV rates and age at diagnosis and self-identified race.

Journal of the National Comprehensive Cancer Network · Jun 2, 2026Peer-reviewedGenetic & Genomic Medicine

Association of HOXB13 G84E with prostate cancer among 592,158 men

Taylor B. Crawford, Tyler J. Nelson, Roshan A. Karunamuni, Heena Desai, Ryan M. Hausler, Craig Carl Teerlink, Hannah K. Carter, Meghana S. Pagadala, Patrick R. Alba, Scott L. DuVall, Morgan E. Danowski, Charles A. Brunette, Dmitry Ratner, Isla P. Garraway, Brent Shane Rose, , Kara N. Maxwell

This paper shows the HOXB13 p.G84E variant increases prostate cancer risk by threefold in men, but does not lead to more aggressive cancer.

Journal of the National Comprehensive Cancer Network · Sep 15, 2025Peer-reviewedGenetic & Genomic Medicine